About Flowbone
Flowbone is a company based in Lausanne (Switzerland) founded in 2014 by Ulrike Kettenberger and Dominique Pioletti. Flowbone has raised $2.14 million across 5 funding rounds from investors including EIT Health, FIT and Venture Kick. Flowbone operates in a competitive market with competitors including Rani Therapeutics, Tarsa Therapeutics, Zosano Pharma, Radius Recycling and Novo Biosciences, among others.
- Headquarter Lausanne, Switzerland
- Founders Ulrike Kettenberger, Dominique Pioletti
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.14 M (USD)
in 5 rounds
-
Latest Funding Round
$2.14 M (USD), Seed
Oct 06, 2022
-
Investors
EIT Health
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Flowbone
Flowbone has successfully raised a total of $2.14M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $2.14 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Flowbone
Flowbone has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include EIT Health, FIT and Venture Kick.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Grants and loans are provided by FIT for innovative startups.
|
Locked | Locked | Locked | |
|
Healthcare startups are accelerated and incubated through specialized programs.
|
Locked | Locked | Locked | |
|
University backed startup accelerator
|
Locked | Locked | Locked |
Investor details for Flowbone
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Flowbone
Investment portfolio details for Flowbone
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Flowbone
Detailed financials for Flowbone
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Flowbone Comparisons
Peer comparison for Flowbone
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Flowbone
Flowbone operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rani Therapeutics, Tarsa Therapeutics, Zosano Pharma, Radius Recycling and Novo Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Technology for oral delivery of large drug molecules is developed.
|
|
| Locked | Locked | Locked |
Oral treatments for postmenopausal osteoporosis are developed.
|
|
| Locked | Locked | Locked |
Develops innovative transdermal drug delivery technologies for various therapeutic applications.
|
|
| Locked | Locked | Locked |
Steel is manufactured and scrap metal is recycled.
|
|
| Locked | Locked | Locked |
Small molecule therapies that reactivate and stimulate innate healing abilities in humans and animals
|
Detailed competitors of Flowbone
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Flowbone
Complete news archive for Flowbone
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Flowbone
Flowbone was founded in 2014 and raised its 1st funding round 5 years after it was founded.
Flowbone is headquartered in Lausanne, Switzerland. It is registered at Lausanne, Vaud, Switzerland.
Flowbone is a funded company, having raised a total of $2.14M across 5 funding rounds to date.
Flowbone was founded in 2014 in Lausanne, Switzerland, within the medical device sector. An injectable biomaterial named Flowbone is produced by the company, targeting osteoporosis through minimally invasive procedures. The material is delivered via a thin cannula into affected bone regions, where natural mineralization is stimulated to form new bone tissue. Operations focus on research and development of this technology for clinical applications.
Flowbone's top competitors include Rani Therapeutics, Radius Recycling and Tarsa Therapeutics.
Flowbone has 3 investors. Key investors include EIT Health, FIT, and Venture Kick.